Mark Basil Swindells
Corporate Officer/Principal chez Exscientia AI Ltd.
Profil
Mark Basil Swindells is currently the Chief Strategy Officer at Exscientia AI Ltd.
He previously held the same position at Exscientia Plc.
Postes actifs de Mark Basil Swindells
| Sociétés | Poste | Début |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Anciens postes connus de Mark Basil Swindells
| Sociétés | Poste | Fin |
|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |